Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, July 31, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New Partnership to Improve Clinical Trial Site Evaluation
Thursday, September 19, 2013
iCTRS partners with ViS Research to help trial planners benefit from a better, more efficient site selection process to accelerate development of much-needed medicines.

Stiris Research Selects CRO Starter Kit™ CTMS by Flex Databases
Tuesday, September 17, 2013
Flex CRO Starter Kit™ manage both internal and external processes of a CRO.

BIOTRONIK Releases Line-Extension of Orsiro Hybrid Drug Eluting Stent
Tuesday, September 03, 2013
The highly deliverable Orsiro stent is now available in lengths up to 40 mm to address a wider range of lesions.

OCT are Expanding the Use of the CTMS Platform with Flex Databases
Thursday, August 29, 2013
Expansion to implement the workflow management tool.

Bio Farma Launches Pentavalent Vaccine, Combining Five Antigens
Tuesday, August 27, 2013
One shot of the vaccine will prevent babies from five diseases at once.

CluePoints Cited in New FDA Guidance for Improved Data Quality
Wednesday, August 14, 2013
CSM techniques have been cited by the FDA in the recent release of the final guidance document detailing the agency's stance on the "Oversight of Clinical Investigations".

Apeiron and Rentschler Announces Partnership Agreement
Friday, August 02, 2013
Rentschler produces Apeiron's monoclonal antibody APN311 for late stage clinical development and market.

Thermo Fisher Scientific Showcases New Small Benchtop Centrifuge at AACC
Thursday, August 01, 2013
Provides scientists with outstanding capacity in a compact design.

Intelsius Introduces Reusable Courier Transit Case
Monday, July 29, 2013
BioCarrier™ - Designed for local courier routes and multiple site sample collections.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 290
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv